Target Price | JPY4,956.21 |
Price | JPY4,295.00 |
Potential |
15.40%
register free of charge
|
Number of Estimates | 14 |
14 Analysts have issued a price target Takeda Pharmaceutical 2026 .
The average Takeda Pharmaceutical target price is JPY4,956.21.
This is
15.40%
register free of charge
JPY5,800.00
35.04%
register free of charge
JPY4,500.00
4.77%
register free of charge
|
|
A rating was issued by 16 analysts: 8 Analysts recommend Takeda Pharmaceutical to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Takeda Pharmaceutical stock has an average upside potential 2026 of
15.40%
register free of charge
|
Mar '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion JPY | 4,581.55 | 4,564.71 |
7.45% | 0.37% | |
EBITDA Margin | 21.52% | 27.31% |
3.66% | 26.92% | |
Net Margin | 2.36% | 5.79% |
30.28% | 145.79% |
14 Analysts have issued a sales forecast Takeda Pharmaceutical 2026 . The average Takeda Pharmaceutical sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Takeda Pharmaceutical EBITDA forecast 2026. The average Takeda Pharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Takeda Pharmaceutical Analysts have issued a net profit forecast 2026. The average Takeda Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share JPY | 68.35 | 167.86 |
25.78% | 145.59% | |
P/E | 25.59 | |
EV/Sales | 2.38 |
7 Analysts have issued a Takeda Pharmaceutical forecast for earnings per share. The average Takeda Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Takeda Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.